Margriet Kwint

Acute esophagus toxicity after IMRT and concurrent chemoradiation 127 6 References 1. Auperin A, Le Pechoux C, Rolland E et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol 2010;28:2181-2190. 2. Belderbos J, Heemsbergen W, Hoogeman M et al. Acute esophageal toxicity in non- small cell lung cancer patients after high dose conformal radiotherapy. Radiother Oncol 2005;75:157-164. 3. Bradley J, Deasy JO, Bentzen S et al. Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma. Int J Radiat Oncol Biol Phys 2004;58:1106- 1113. 4. Caglar HB, Othus M, Allen AM. Esophagus in-field: a new predictor for esophagitis. Radiother Oncol 2010;97:48-53. 5. Dehing-Oberije C, De Ruysscher D, Petit S et al. Development, external validation and clinical usefulness of a practical prediction model for radiation-induced dysphagia in lung cancer patients. Radiother Oncol 2010;97:455-461. 6. Rose J, Rodrigues G, Yaremko B et al. Systematic review of dose-volume parameters in the prediction of esophagitis in thoracic radiotherapy. Radiother Oncol 2009;91:282-287. 7. Werner-Wasik M, Yorke E, Deasy J et al. Radiation dose-volume effects in the esophagus. Int J Radiat Oncol Biol Phys 2010;76:S86-S93. 8. Chapet O, Thomas E, Kessler ML et al. Esophagus sparing with IMRT in lung tumor irradiation: an EUD-based optimization technique. Int J Radiat Oncol Biol Phys 2005;63:179-187. 9. Chapet O, Fraass BA, Ten Haken RK. Multiple fields may offer better esophagus sparing without increased probability of lung toxicity in optimized IMRT of lung tumors. Int J Radiat Oncol Biol Phys 2006;65:255-265. 10. Schwarz M, Alber M, Lebesque JV et al. Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2005;62:561-570. 11. Wolthaus JW, Schneider C, Sonke JJ et al. Mid-ventilation CT scan construction from four- dimensional respiration-correlated CT scans for radiotherapy planning of lung cancer patients. Int J Radiat Oncol Biol Phys 2006;65:1560-1571. 12. van Herk M. Errors and margins in radiotherapy. Semin Radiat Oncol 2004;14:52-64. 13. Belderbos J, Uitterhoeve L, van Zandwijk N et al. Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973). Eur J Cancer 2007;43:114-121. 14. Uitterhoeve AL, Belderbos JS, Koolen MG et al. Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer: results of the EORTC 08912 phase I/II study. European Organization for Research and Treatment of Cancer. Eur J Cancer 2000;36:592-600. 15. Uyterlinde W, van den Heuvel M, Belderbos J. Correlation of co-morbidity, patient characteristics and the occurrence of toxicity due to concurrent, sequential chemo radiotherapy or high dose radiotherapy alone, in patients with locally advanced non small cell lung cancer. Abstract P4-238, 07-2011. World Conference of Lung Cancer.